Yüklüyor......
Immunotherapy for advanced hepatocellular carcinoma: a focus on special subgroups
Following the success of immune checkpoint blockers (ICBs) in different cancer types, a large number of studies are currently investigating ICBs in patients with hepatocellular carcinoma (HCC), alone or in combination with other treatments. Both nivolumab and pembrolizumab, as well as the combinatio...
Kaydedildi:
| Yayımlandı: | Gut |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BMJ Publishing Group
2021
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7788203/ https://ncbi.nlm.nih.gov/pubmed/32747413 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/gutjnl-2020-321702 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|